US-201 — New Haven, Connecticut

US-201 is a clinical research site located in New Haven, Connecticut, United States 06519.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

US-201 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Advanced Solid Tumor.

Sponsors: MediLink Therapeutics (Suzhou) Co., Ltd..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in New Haven

Browse all research sites in Connecticut · View every site in New Haven

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for US-201?

US-201 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has US-201 conducted?

US-201 has 1 clinical trials on record, with 1 currently active. Their work covers Advanced Solid Tumor.

Is US-201 accredited by Crixeo Clinical Trials?

US-201 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about US-201?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.